Unicycive Therapeutics Announced Results From The Oxylanthanum Carbonate UNI-OLC-201 Pivotal Trial, Established Favorable Tolerability And Safety And New Drug Application Submission Anticipated In Q3 2024
Unicycive Therapeutics宣佈從氧鑭碳酸鹽UNI-OLC-201關鍵試驗中獲得積極結果,表明該藥具有良好的耐受性和安全性,新藥申請將於2024年Q3提交。